High Numbers of Tumor-Associated Macrophages Have an Adverse Prognostic Value That Can Be Circumvented by Rituximab in Patients With Follicular Lymphoma Enrolled Onto the GELA-GOELAMS FL-2000 Trial

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

2002 • 5,109 citations

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

1999 • 3,484 citations

Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues

2003 • 2,031 citations

Follicular lymphoma international prognostic index.

2004 • 1,553 citations

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

2004 • 1,395 citations

Follicular lymphoma international prognostic index

2006 • 1,262 citations

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma

2006 • 491 citations

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)

2005 • 457 citations

Rituximab: Mechanism of action and resistance

2002 • 360 citations

Classical and alternative activation of mononuclear phagocytes: Picking the best of both worlds for tumor promotion

2006 • 359 citations

Gene-Expression and Immunohistochemical Study of Specific T-Cell Subsets and Accessory Cell Types in the Transformation and Prognosis of Follicular Lymphoma

2007 • 248 citations

Immunohistochemical Patterns of Reactive Microenvironment Are Associated With Clinicobiologic Behavior in Follicular Lymphoma Patients

2006 • 232 citations

Number of CD4⁺ Cells and Location of Forkhead Box Protein P3–Positive Cells in Diagnostic Follicular Lymphoma Tissue Microarrays Correlates With Outcome

2006 • 230 citations

Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment

2004 • 227 citations

Ex Vivo-activated Human Macrophages Kill Chronic Lymphocytic Leukemia Cells in the Presence of Rituximab: Mechanism of Antibody-dependent Cellular Cytotoxicity and Impact of Human Serum

2006 • 103 citations

The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

2006 • 96 citations

Treatment Strategies in Follicular Lymphomas: Current Status and Future Perspectives

2005 • 86 citations

Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma

2003 • 67 citations

High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma

2004 • 66 citations

Increased Vascularization Predicts Favorable Outcome in Follicular Lymphoma

2005 • 62 citations

The CCL3 Family of Chemokines and Innate Immunity Cooperate In Vivo in the Eradication of an Established Lymphoma Xenograft by Rituximab

2007 • 51 citations

Update of the FL2000 randomized trial combining rituximab to CHVP-Interferon in follicular lymphoma (FL) patients (pts)

2006 • 34 citations

Prognostic significance of PU.1 in follicular lymphoma

2006 • 25 citations

Immunohistochemical analysis of the antiapoptotic Mcl‐1 and Bcl‐2 proteins in follicular lymphoma

2006 • 21 citations

Previous Issues

2002 • 9 citations